Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study evaluates a thyroid-function-preserving alternative to routine total thyroidectomy for bilateral papillary thyroid carcinoma (PTC). Eligible adults undergo remote-access gas-less axillo-breast endoscopic hemithyroidectomy with level VI dissection on the dominant side, followed by ultrasound-guided radiofrequency ablation (RFA) of a ≤7 mm contralateral focus during the same anesthesia. Outcomes include structural-recurrence-free survival, endocrine-function preservation, safety, and quality of life over 24 months.

Who May Be Eligible (Plain English)

Who May Qualify: - Age 18-65 years. - Dominant-side PTC ≤1.5 cm suitable for endoscopic resection. - Contralateral nodule ≤7 mm located ≥2 mm from posterior capsule. - No radiologic lymph-node metastasis on contralateral side. - Written willing to sign a consent form. Who Should NOT Join This Trial: - Extrathyroidal extension, gross nodal or distant metastasis. - Prior neck surgery, prior RFA/ethanol injection, or neck irradiation. - Pregnancy or lactation. - Serious comorbidities precluding anesthesia or follow-up. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age 18-65 years. * Dominant-side PTC ≤1.5 cm suitable for endoscopic resection. * Contralateral nodule ≤7 mm located ≥2 mm from posterior capsule. * No radiologic lymph-node metastasis on contralateral side. * Written informed consent. Exclusion Criteria: * Extrathyroidal extension, gross nodal or distant metastasis. * Prior neck surgery, prior RFA/ethanol injection, or neck irradiation. * Pregnancy or lactation. * Serious comorbidities precluding anesthesia or follow-up.

Treatments Being Tested

PROCEDURE

Endoscopic Hemithyroidectomy with Central-Neck Dissection

Gas-less axillo-breast approach (trans-axillary + peri-areolar), carbon-dioxide-free working space, removing dominant thyroid lobe plus level VI lymph nodes; intra-operative neuromonitoring used throughout.

PROCEDURE

Ultrasound-Guided Radiofrequency Ablation of Contralateral Nodule

17-gauge internally-cooled electrode, 0.7 cm active tip, power 40 W; moving-shot technique under real-time ultrasound until hyperechoic halo fully covers ≤ 7 mm papillary microcarcinoma ≥ 2 mm from posterior capsule; same anesthesia session as surgery.

Locations (1)

Fujian Medical University Union Hospital
Fuzhou, Fujian, China